PCM
KYNB

Penserra Capital Management’s Kyntra Bio KYNB Stock Holding History

Penserra Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-85
Closed -$21K – 1423
2021
Q3 		$21K Buy
85
+1
+1% +$354 ﹤0.01% 1234
2021
Q2 		$55K Buy
84
+2
+2% +$1.15K ﹤0.01% 970
2021
Q1 		$71K Sell
82
-1
-1% -$1.06K ﹤0.01% 757
2020
Q4 		$77K Buy
83
+52
+168% +$54.7K ﹤0.01% 624
2020
Q3 		$31K Buy
+31
New +$33.4K ﹤0.01% 685

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Penserra Capital Management's KYNB Position: Q4 2021 in Review

Penserra Capital Management sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 85 shares — an estimated $21K sold.

Penserra Capital Management first reported a position in KYNB in Q3 2020 and held it in 5 quarters. The position peaked at $77K in Q4 2020. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Penserra Capital Management reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 85 Kyntra Bio shares in Q4 2021, an estimated $21K.
  • Penserra Capital Management first reported a position in Kyntra Bio in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Kyntra Bio position peaked at $77K in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.